
Sanofi (SNY)
NASDAQ
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Return on Assets (%) | 8.231 | 4.077 | 2.504 | 10.825 | 5.304 | 6.779 | 4.266 | 4.289 |
Return on Equity (%) | 14.515 | 7.343 | 4.75 | 20.095 | 9.409 | 11.612 | 7.224 | 7.306 |
Return on Invested Capital (%) | 17.844 | 13.954 | 11.531 | 10.225 | 10.426 | 12.823 | 11.297 | 10.837 |
Operating Margin (%) | 35.142 | 14.172 | 9.11 | 39.702 | 21.755 | 25.311 | 19.362 | 17.197 |
Net Profit Margin (%) | 23.996 | 12.495 | 7.767 | 34.111 | 16.48 | 19.469 | 12.538 | 12.058 |
Book Value Per Share | 3.903 | -5.683 | -1.582 | 0.434 | -0.342 | 2.871 | 0.498 | 9.377 |
Earnings Per Share | 6.711 | 3.452 | 2.238 | 9.765 | 4.925 | 6.639 | 4.269 | 4.402 |
Cash Per Share | 8.226 | 5.552 | 7.518 | 11.053 | 7.992 | 10.101 | 6.886 | 5.891 |
Working Capital Per Share | 8.685 | 5.774 | 6.564 | 11.522 | 7.336 | 7.98 | 5.108 | 10.629 |
Operating Profit Per Share | 21.094 | 21.495 | 22.921 | 21.831 | 22.904 | 27.638 | 27.295 | 30.792 |
EBIT Per Share | 9.469 | 3.519 | 2.251 | 10.944 | 6.171 | 8.266 | 5.655 | 5.543 |
EBITDA Per Share | 9.469 | 3.519 | 2.251 | 10.944 | 6.171 | 8.266 | 5.655 | 5.543 |
Free Cash Flow Per Share | 8.814 | 5.349 | 3.869 | 12.029 | 7.403 | 9.027 | 7.482 | 8.036 |
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 1,25B | 1,25B | 1,25B | 1,26B | 1,26B | 1,26B | 1,26B | 1,26B |
Fin d'année 31 Décembre 2024 | Juin 2022 | Sept 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Actions en circulation | 1,27B | 1,25B | 1,25B | 1,26B | 1,25B | 1,25B | 1,27B | 1,25B |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 22.24 | 25.67 | N/A | 28.034 | 15.291 | N/A | 28.04 |
Net Profit Margin (%) | N/A | 16.632 | 19.517 | N/A | 21.105 | 10.828 | N/A | 20.948 |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 149,68B |
Ratio cours/bénéfice | 49,81 |
Ratio prix/ventes | 6,01 |
Ratio prix/liquidités | 37,22 |
Ratio prix/valeur comptable | 3,56 |
Rendement de dividende | 664,52% |
Actions en circulation | 2,53B |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales